Acetylcysteine for Prevention of Renal Outcomes in Patients Undergoing Coronary and Peripheral Vascular Angiography Main Results From the Randomized Acetylcysteine for Contrast-Induced Nephropathy Trial (ACT)

被引：252

作者：

Berwanger, Otavio ^{[1
,2
]}

Cavalcanti, Alexandre B. ^{[1
,2
]}

Sousa, Amanda G. M. R. ^{[1
,2
]}

Buehler, Anna M. ^{[1
,2
]}

Kodama, Alessandra A. ^{[1
,2
]}

Carballo, Mariana T. ^{[1
,2
]}

Carvalho, Vitor O. ^{[1
]}

Amodeo, Celso ^{[1
,2
]}

Lotaif, Leda D. ^{[1
,2
]}

Sousa, Jose Eduardo ^{[1
,2
]}

Victor, Elivane S. ^{[2
]}

Santucci, Eliana ^{[2
]}

Cardoso, Carlos E. S. ^{[2
]}

da Silva, Dalmo ^{[2
]}

Mendes, Adailton L. ^{[2
]}

Lobato, Jose ^{[2
]}

Prates, G. ^{[3
]}

Yokoyama, H. ^{[3
]}

Almeida, P. ^{[3
]}

Pessoa, C. ^{[3
]}

Martins, H. ^{[4
]}

Lopes, M. ^{[4
]}

Barros, M. ^{[4
]}

Reis, H. ^{[5
]}

Cordeiro, C. ^{[5
]}

Castello, H. ^{[6
]}

Cantarelli, M. ^{[6
]}

Ferreira, S. ^{[6
]}

Mattos, C. ^{[7
,10
,21
]}

Rati, M. ^{[7
]}

Medeiros, C. ^{[7
]}

Mangione, J. A. ^{[8
]}

Mauro, M. F. ^{[8
]}

Cristovao, S. A. ^{[8
]}

Carnieto, N. M. ^{[8
]}

Rocha, L. C. ^{[8
]}

Maksud, D. F. ^{[8
]}

Barbosa, C. ^{[8
]}

Costantini, C. ^{[9
]}

Tarbine, S. ^{[9
]}

Santos, M. ^{[9
]}

Ortiz, C. ^{[9
]}

Souza, A. ^{[9
]}

Mattos, C. ^{[7
,10
,21
]}

Duarte, L. ^{[10
]}

Marin Neto, J. ^{[11
]}

Figueiredo, G. ^{[11
]}

Lemos, D. ^{[11
]}

Braga, F. ^{[11
]}

Novaes, G. ^{[11
]}

机构：

[1] Hosp Coracao HCor, Res Inst, BR-04005000 Sao Paulo, Brazil

[2] Inst Dante Pazzanese Cardiol, Sao Paulo, Brazil

[3] Associacao Hosp Bauru, Sao Paulo, Brazil

[4] Cardioctr Hosp Santa Paula, Joao Pessoa, Paraiba, Brazil

[5] Fundacao Publ Estadual Hosp Gaspar Vianna, Belem, Para, Brazil

[6] Hosp Bandeirantes, Sao Paulo, Brazil

[7] Hosp Barra Dor, Rio De Janeiro, Brazil

[8] Hosp Beneficencia Portuguesa, Sao Paulo, Brazil

[9] Hosp Cardiol Constantini, Curitiba, Parana, Brazil

[10] Hosp Copa Dor, Rio De Janeiro, Brazil

[11] Univ Sao Paulo, Fac Med Ribeirao Preto, Hosp Clin, Sao Paulo, Brazil

[12] Fac Fed Pernambuco, Hosp Clin, Recife, PE, Brazil

[13] Hosp Terapia Intens HTI, Teresina, Piaui, Brazil

[14] Hosp Coracao Juiz de Fora, Juiz De Fora, MG, Brazil

[15] Hosp Coracao Sao Paulo, Sao Paulo, Brazil

[16] Hosp Coracao Brasil, Brasilia, DF, Brazil

[17] Hosp Escola Alvaro Alvim, Rio De Janeiro, Brazil

[18] Hosp Felicio Rocho, Belo Horizonte, MG, Brazil

[19] Hosp Maternidade Pronto Socorro Santa Lucia, Pocos De Caldas, MG, Brazil

[20] Hosp Moinhos Vento, Porto Alegre, RS, Brazil

[21] Hosp Quinta Dor, Rio De Janeiro, Brazil

[22] Hosp Reg Sul de Minas, Varginha, MG, Brazil

[23] Hosp Samaritano, Sao Paulo, Brazil

[24] Hosp Santa Catarina, Blumenau, SC, Brazil

[25] Hosp Santa Helena Sao Francisco Cardio Vida, Aparecida De Goiania, Go, Brazil

[26] Hosp Santa Lucinda, Sao Paulo, Brazil

[27] Hosp Santa Marcelina, Sao Paulo, Brazil

[28] Hosp Sao Jose Avai, Itaperuna, RJ, Brazil

[29] Hosp SOS Cardio, Florianopolis, SC, Brazil

[30] Hosp UDI, Sao Luis, Maranhao, Brazil

[31] Hosp Univ Sao Jose, Belo Horizonte, MG, Brazil

[32] INCOR Hemocardio, Natal, RN, Brazil

[33] INCORPI Hosp Fornecedores Cana, Sao Paulo, Brazil

[34] Inst Cardiol, Sao Jose, SC, Brazil

[35] Inst Cardiol RGS Fundacao Univ Cardiol, Porto Alegre, RS, Brazil

[36] Juiz de Fora Hosp Monte Sinai, Inst Clin & Cirurgia, Juiz De Fora, MG, Brazil

[37] Inst Molestias Cardiovasc, Sao Paulo, Brazil

[38] Inst Coracao Triangulo Mineiro, Uberlandia, MG, Brazil

[39] Inst Coracao Taguatinga Hosp Anchieta, Taguatinga, DF, Brazil

[40] Inst Nacl Cardiol Laranjeiras, Rio De Janeiro, Brazil

[41] Natal Hosp Ctr, Natal, RN, Brazil

[42] Santa Casa Limeira, Sao Paulo, Brazil

[43] Santa Casa Marilia, Sao Paulo, Brazil

[44] Santa Casa Misericordia Juiz de Fora, Juiz De Fora, MG, Brazil

[45] Santa Casa Porto Alegre, Porto Alegre, RS, Brazil

[46] Santa Casa Sao Paulo, Sao Paulo, Brazil

[47] UNISUL Hosp Socimed, Tubarao, SC, Brazil

来源：

CIRCULATION | 2011年 / 124卷 / 11期

关键词：

acute kidney injury; coronary angiogram; contrast media; angioplasty; acetylcysteine; N-ACETYLCYSTEINE; INTERVENTION; FAILURE; METAANALYSIS; RISK; NEPHROTOXICITY; ASSOCIATION; GUIDELINES; QUALITY; IMPACT;

D O I：

10.1161/CIRCULATIONAHA.111.038943

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Background-It remains uncertain whether acetylcysteine prevents contrast-induced acute kidney injury. Methods and Results-We randomly assigned 2308 patients undergoing an intravascular angiographic procedure with at least 1 risk factor for contrast-induced acute kidney injury (age >70 years, renal failure, diabetes mellitus, heart failure, or hypotension) to acetylcysteine 1200 mg or placebo. The study drugs were administered orally twice daily for 2 doses before and 2 doses after the procedure. The allocation was concealed (central Web-based randomization). All analysis followed the intention-to-treat principle. The incidence of contrast-induced acute kidney injury (primary end point) was 12.7% in the acetylcysteine group and 12.7% in the control group (relative risk, 1.00; 95% confidence interval, 0.81 to 1.25; P = 0.97). A combined end point of mortality or need for dialysis at 30 days was also similar in both groups (2.2% and 2.3%, respectively; hazard ratio, 0.97; 95% confidence interval, 0.56 to 1.69; P = 0.92). Consistent effects were observed in all subgroups analyzed, including those with renal impairment. Conclusions-In this large randomized trial, we found that acetylcysteine does not reduce the risk of contrast-induced acute kidney injury or other clinically relevant outcomes in at-risk patients undergoing coronary and peripheral vascular angiography.

引用

页码：1250 / 1259

页数：10

共 44 条

[1] [Anonymous], 2006, J Am Coll Cardiol, V47, pe1e121, DOI DOI 10.1016/j.jacc.2005.12.001
[2] Acetylcysteine in the prevention of contrast-induced nephropathy - A case study of the pitfalls in the evolution of evidence
Bagshaw, SM
McAlister, FA
Manns, BJ
Ghali, WA
[J]. ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (02) : 161 - 166
[3] Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification
Bartholomew, BA
Harjai, KJ
Dukkipati, S
Boura, JA
Yerkey, MW
Glazier, S
Grines, CL
O'Neill, WW
[J]. AMERICAN JOURNAL OF CARDIOLOGY, 2004, 93 (12) : 1515 - 1519
[4] Benko A, 2007, CAN ASSOC RADIOL J, V58, P79
[5] Standard vs double dose of N-acetylcysteine to prevent contrast agent associated nephrotoxicity
Briguori, C
Colombo, A
Violante, A
Balestrieri, P
Manganelli, F
Elia, PP
Golia, B
Lepore, S
Riviezzo, G
Scarpato, P
Focaccio, A
Librera, M
Bonizzoni, E
Ricciardelli, B
[J]. EUROPEAN HEART JOURNAL, 2004, 25 (03) : 206 - 211
[6] Buyse M, 1999, STAT MED, V18, P3435, DOI 10.1002/(SICI)1097-0258(19991230)18:24<3435::AID-SIM365>3.0.CO
[7] 2-O
[8] CAIXETA A, 2010, CATHETER CARDIOVASC, V75, P15
[9] Rationale, design, and baseline characteristics of the Acetylcystein for Contrast-Induced nephropaThy (ACT) Trial: a pragmatic randomized controlled trial to evaluate the efficacy of acetylcysteine for the prevention of contrast-induced nephropathy
Costa, Eduardo
Reis, Helder
de Assis, Gabriela M. C. C.
Cardoso, Gracilene L.
Barbosa, Marcio M.
de Aguiar Filho, Francisco A. A.
Gama, Carlos A. V.
Silva, Marcelo Goes A.
Aguiar, Bruno M.
Ferreira, Marcelo G.
Feitosa, Gilson S.
Victor Filho, Edgard
Rocha, Emmanuel B. D.
Paiva, Maria S. M. O.
Czochra, Eliana R.
Oliveira, Ludmila A. R. R.
de Oliveira, Itamar R.
Pinheiro, Flavia
Dourado, Gilvan O.
Luna Filho, Antonio L.
Pacheco, Amilson
Nunes, Paulo M. S.
de Sa Filho, Alcino P.
Martins, Helman C.
Lopes, Marcelo A. C.
Barros, Marco A. V.
Mattos, Claudia
Neves, Miguel A.
Medeiros, Cesar Rocha
Duarte, Leonardo
Cramer, Helena
Santos, Braulio, Jr.
Tura, Bernardo R.
Rodrigues, Cyro V.
Terreiro, Luis A. O.
Alves, Monica A.
Soares, Jamil S.
da Cunha, Cristiane C.
da Silva, Antonio C. B.
Barcelos, Alexandre M.
Teixeira, Marco A.
Pinto, Joselena S.
Saad, Jamil A.
Mandil, Ari
Falcheto, Eduardo
Areas, Carlos Augusto F.
Dall'Orto, Frederico T. C.
Freitas, Ivan F.
Botelho, Roberto V.
Seabra, Miriam D. G.
[J]. TRIALS, 2009, 10
[10] Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables
Dangas, G
Iakovou, I
Nikolsky, E
Aymong, ED
Mintz, GS
Kipshidze, NN
Lansky, AJ
Moussa, I
Stone, GW
Moses, JW
Leon, MB
Mehran, R
[J]. AMERICAN JOURNAL OF CARDIOLOGY, 2005, 95 (01) : 13 - 19

← 1 2 3 4 5 →